Assuntos
Antimaláricos/administração & dosagem , Antimaláricos/sangue , Naftoquinonas/administração & dosagem , Naftoquinonas/sangue , Proguanil/administração & dosagem , Animais , Antimaláricos/farmacocinética , Antimaláricos/farmacologia , Atovaquona , Bioensaio , Cromatografia Líquida de Alta Pressão , Quimioterapia Combinada , Meia-Vida , Humanos , Malária Falciparum/tratamento farmacológico , Naftoquinonas/farmacocinética , Naftoquinonas/farmacologia , Plasmodium falciparum/efeitos dos fármacos , Plasmodium falciparum/genética , Proguanil/farmacocinética , Proguanil/farmacologiaRESUMO
The study was a comparison of bioassay and HPLC analysis of artesunate (ARTS) and dihydroartemisinin (DHA) in plasma. ARTS and DHA in plasma samples from patients treated with ARTS were quantified by HPLC and expressed as DHA. DHA-equivalents in the same plasma samples were measured using a standardised parasite culture technique. DHA concentrations estimated by both methods were highly correlated (bioassay=0.96 x HPLC+11.0; r2=0.92). At high concentrations (>12000 nmol/l) bioassay sometimes overestimated DHA. Bioassay of active drug in plasma correlates well with specific chemical analysis by HPLC. ARTS and DHA appear to account for the total antimalarial activity in plasma after ARTS administration.
Assuntos
Antimaláricos/sangue , Artemisininas/sangue , Malária Falciparum/sangue , Plasmodium falciparum , Sesquiterpenos/sangue , Animais , Antimaláricos/uso terapêutico , Artemisininas/uso terapêutico , Artesunato , Bioensaio , Cromatografia Líquida de Alta Pressão , Humanos , Concentração Inibidora 50 , Malária Falciparum/tratamento farmacológico , Sesquiterpenos/uso terapêuticoRESUMO
A total of 34 analogues of the biguanide PS-15 (5s), a prodrug of the diaminotriazine WR-99210 (8s), have been prepared. Several of them, such as 5b (PS-33) and 5m (PS-26), maintain or exceed the in vivo activity of PS-15 while not requiring the use of highly regulated starting materials. The putative diaminotriazine metabolites of these new analogues (compounds 8) have also been prepared and shown to maintain the activity against resistant P. falciparum strains. The structure-activity relationships of biguanides 5 and putative metabolites 8 are discussed.
Assuntos
Antimaláricos/síntese química , Antagonistas do Ácido Fólico/síntese química , Guanidinas/síntese química , Pró-Fármacos/síntese química , Proguanil/análogos & derivados , Proguanil/síntese química , Tetra-Hidrofolato Desidrogenase/metabolismo , Triazinas/síntese química , Animais , Antimaláricos/química , Antimaláricos/farmacologia , Antimaláricos/toxicidade , Avaliação Pré-Clínica de Medicamentos , Feminino , Antagonistas do Ácido Fólico/química , Antagonistas do Ácido Fólico/farmacologia , Antagonistas do Ácido Fólico/toxicidade , Guanidinas/química , Guanidinas/farmacologia , Guanidinas/toxicidade , Malária/tratamento farmacológico , Masculino , Camundongos , Plasmodium berghei , Plasmodium falciparum/efeitos dos fármacos , Pró-Fármacos/química , Pró-Fármacos/farmacologia , Pró-Fármacos/toxicidade , Proguanil/química , Proguanil/farmacologia , Proguanil/toxicidade , Relação Estrutura-Atividade , Triazinas/química , Triazinas/farmacologia , Triazinas/toxicidadeRESUMO
On the basis of a systematic SAR analysis of substituted quinolines, a derivative 32 was synthesized that shows half-maximal inhibition of the immunostimulatory effect of CpG-oligodeoxynucleotides in vitro at the concentration of 0.24 nM.
Assuntos
Aminoquinolinas/síntese química , Aminoquinolinas/farmacologia , Oligonucleotídeos/antagonistas & inibidores , Cloroquina/análogos & derivados , Ilhas de CpG/imunologia , Cinética , Relação Estrutura-AtividadeRESUMO
Plasma chloroquine (CQ) concentrations were measured by bioassay in young (0-4 years, n = 9) and older (5-60 years, n = 21) patients from Vanuatu infected with malaria following treatment with 25 mg/kg CQ over 3 days. CQ concentrations in young children tended to be lower than in older patients at days 2, 3, 4 and 7 after onset of treatment, with no drug present in two young children on day 3 and in one child on day 7. The greater difficulty experienced by young children to ingest all of their prescribed medication could have contributed to the lower CQ concentrations observed in the younger age group. The possibility that sub-therapeutic CQ concentrations are responsible for treatment failures in young children should be considered in areas where a high degree of CQ resistance has not yet been established. In such areas, the presence or prevalence of CQ-resistant infections should not be based on treatment failures observed in young children unless it can be confirmed that adequate blood CQ concentrations were achieved after treatment.
Assuntos
Antimaláricos/sangue , Cloroquina/sangue , Adolescente , Adulto , Criança , Pré-Escolar , Cloroquina/uso terapêutico , Resistência a Medicamentos , Humanos , Lactente , Recém-Nascido , Pessoa de Meia-IdadeRESUMO
We have compared the ex vivo antimalarial activity of 12 new quinoline di-Mannich base compounds containing the 7-dichloroquinoline or 7-trifluoromethylquinoline nucleus with amodiaquine, chloroquine, and pyronaridine using the Saimiri-bioassay model. Each compound was administered orally (30 mg/kg of body weight) to three or more noninfected Saimiri sciureus monkeys, and serum samples were collected at various times after drug administration and serially diluted with drug-free (control) serum. In vitro activity against the multidrug-resistant K1 isolate of Plasmodium falciparum was determined in serum samples by measuring the maximum inhibitory dilution at which the treated monkey serum inhibited schizont maturation in vitro. Of the 12 Mannich bases tested, 8 were associated with levels of ex vivo antimalarial activity in serum greater than those of amodiaquine, chloroquine, or pyronaridine 1 to 7 days after drug administration. Further studies were carried out with four of these compounds, and the results showed that the areas under the serum drug concentration-time curves for the four compounds were between 7- and 26-fold greater than that obtained for pyronaridine. Activity against four multidrug-resistant strains of P. falciparum was also much greater in serum samples collected from monkeys after administration of these four compounds than in serum samples collected after administration of pyronaridine or chloroquine. These findings suggest that these four quinoline Mannich base compounds possess a very marked and prolonged antimalarial activity and that further studies should be performed to determine their value as antimalarial drugs.
Assuntos
Antimaláricos/farmacologia , Bases de Mannich/farmacologia , Quinolinas/farmacologia , Amodiaquina/farmacologia , Animais , Antimaláricos/sangue , Cloroquina/farmacologia , Bases de Mannich/sangue , Testes de Sensibilidade Microbiana , Naftiridinas/farmacologia , Plasmodium falciparum/efeitos dos fármacos , Quinolinas/sangue , Saimiri , Relação Estrutura-AtividadeRESUMO
In this study we describe the application of a bioassay for measuring chloroquine equivalent concentrations in plasma samples obtained from soldiers on chloroquine (300 mg weekly) and doxycycline (50 or 100 mg daily) for malaria prophylaxis. Chloroquine, its principal metabolite monodesethylchloroquine and doxycycline were also measured by high performance liquid chromatography (HPLC). Physiological concentrations of doxycycline did not interfere with the measurement of chloroquine equivalent concentrations. The correlation between bioassay and HPLC was rs = 0.88, with a median bioassay/HPLC chloroquine concentration ration of 1.1 (range 0.6-2.4, n = 26). The bioassay is a valuable method, particularly under field conditions, for measuring chloroquine concentrations and can be very helpful in distinguishing drug failures from either poor compliance or inadequate drug absorption.
Assuntos
Antimaláricos/sangue , Antimaláricos/uso terapêutico , Cloroquina/sangue , Cloroquina/uso terapêutico , Doxiciclina/sangue , Malária/prevenção & controle , Austrália , Bioensaio , Cromatografia Líquida de Alta Pressão , Doxiciclina/uso terapêutico , Humanos , Militares , Distribuição Aleatória , Análise de RegressãoRESUMO
The bioassay technique and high-performance liquid chromatography (HPLC) method were used to establish chloroquine (CQ) concentration equivalents in serum samples collected from Aotus and Saimiri monkeys after administration of CQ. The results indicate some differences in CQ metabolism between the two simian species. They also indicate a strong positive relationship (rs = 0.96) between data obtained by the bioassay and HPLC technique. The findings suggest that the use of the bioassay in these small primates, using only a fraction of the serum required for HPLC analysis, should provide a useful mean for obtaining preliminary information about the degree and duration of serum antimalarial activity of promising experimental drugs. Apart from reducing the number of monkeys required for drug evaluation, this in vivo-in vitro model should also decrease the overall cost and duration of developing new antimalarial agents.
Assuntos
Aotus trivirgatus/sangue , Cloroquina/análogos & derivados , Cloroquina/sangue , Plasmodium falciparum/crescimento & desenvolvimento , Saimiri/sangue , Animais , Bioensaio , Cromatografia Líquida de Alta Pressão , Meios de Cultura , Resistência a Medicamentos , Humanos , Plasmodium falciparum/efeitos dos fármacosRESUMO
The in vitro microculture technique was used to develop a relatively simple bioassay for estimating chloroquine (CQ) in plasma or serum. Chloroquine concentrations were determined by multiplying the maximum inhibitory dilution of plasma/serum required to inhibit growth of the CQ-sensitive FC27 isolate of Plasmodium falciparum by the minimum inhibitory concentration of CQ against the same isolate. Human serum samples spiked with CQ gave similar measurements using both bioassay and high-performance liquid chromatography. The antimalarial activity of plasma or serum samples collected from 13 patients treated with CQ was equivalent to the sum of the combined activity of CQ and its metabolite, mono-desethylchloroquine. The concentration of these components using the bioassay could be expressed conveniently in terms of CQ concentration equivalents. This bioassay can be used to estimate drug concentrations without the use of sophisticated methods or equipment. Since it is based on the microculture technique, it can be easily carried out in conjunction with the drug susceptibility test to assess CQ treatment failures in malaria patients.